Ginsenoside Rg3 targets cancer stem cells and tumor angiogenesis to inhibit colorectal cancer progression in vivo
Yuchen Tang(Soochow University), Wěi Li(Shougang (China)), Min Tao(Hunan Normal University), Bairong Shen(Sichuan University), Lu Liu(Weifang Medical University), Yan Zhang(Guangzhou Center for Disease Control and Prevention), Jin Zhou(Soochow University), Dongmei Gu(Tianjin Medical University General Hospital), Mengyao Wu(Soochow University), Meng Shen(Soochow University), Yuan Gao(Peking University), Qiaoming Zhi(First Affiliated Hospital of Soochow University), Mengdan Xu(Soochow University), Jie Yu(Inner Mongolia Agricultural University)
Cited by 116
Related Papers
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
|New England Journal of Medicine|2022|2.5k
HIF-1α pathway: role, regulation and intervention for cancer therapy
|Acta Pharmaceutica Sinica B|2015|1.9k
The BACE1 inhibitor verubecestat (MK-8931) reduces CNS β-amyloid in animal models and in Alzheimer’s disease patients
|Science Translational Medicine|2016|416
Multiple Reaction Monitoring of mTRAQ-Labeled Peptides Enables Absolute Quantification of Endogenous Levels of a Potential Cancer Marker in Cancerous and Normal Endometrial Tissues
|Journal of Proteome Research|2008|172
AKR1B1 promotes basal-like breast cancer progression by a positive feedback loop that activates the EMT program
|The Journal of Experimental Medicine|2017|171